Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.verified

CRL

Price:

$199.56

Market Cap:

$10.20B

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, includi...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2000-06-23

Stock Exchange

NYSE

Ticker

CRL

The Enterprise Value as of December 2024 (TTM) for Charles River Laboratories International, Inc. (CRL) is 12.75B

According to Charles River Laboratories International, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.75B. This represents a change of -11.51% compared to the average of 14.41B of the last 4 quarters.

Charles River Laboratories International, Inc. (CRL) Historical Enterprise Value (quarterly & annually)

How has CRL Enterprise Value performed in the past?

The mean historical Enterprise Value of Charles River Laboratories International, Inc. over the last ten years is 9.94B. The current 12.75B Enterprise Value has changed 12.73% with respect to the historical average. Over the past ten years (40 quarters), CRL's Enterprise Value was at its highest in in the September 2021 quarter at 26.07B. The Enterprise Value was at its lowest in in the December 2014 quarter at 3.60B.

Quarterly (TTM)
Annual

Average

9.94B

Median

8.00B

Minimum

3.62B

Maximum

21.25B

Charles River Laboratories International, Inc. (CRL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Charles River Laboratories International, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 56.81%

Maximum Annual Enterprise Value = 21.25B

Minimum Annual Increase = -34.41%

Minimum Annual Enterprise Value = 3.62B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202314.90B6.92%
202213.94B-34.41%
202121.25B47.76%
202014.38B56.81%
20199.17B34.28%
20186.83B10.54%
20176.18B31.47%
20164.70B5.17%
20154.47B23.59%
20143.62B18.39%

Charles River Laboratories International, Inc. (CRL) Average Enterprise Value

How has CRL Enterprise Value performed in the past?

The current Enterprise Value of Charles River Laboratories International, Inc. (CRL) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

16.69B

5-year avg

14.73B

10-year avg

9.94B

Charles River Laboratories International, Inc. (CRL) Enterprise Value vs. Peers

How is CRL’s Enterprise Value compared to its peers?

Charles River Laboratories International, Inc.’s Enterprise Value is less than ICON Public Limited Company (20.51B), less than Mettler-Toledo International Inc. (28.42B), greater than Syneos Health, Inc. (7.24B), less than Laboratory Corporation of America Holdings (26.39B), less than Waters Corporation (24.43B), less than IDEXX Laboratories, Inc. (36.14B), less than IQVIA Holdings Inc. (48.41B), less than Revvity, Inc. (16.13B), greater than Invitae Corporation (1.36B), greater than CareDx, Inc (1.27B), greater than Guardant Health, Inc. (4.99B), less than Illumina, Inc. (24.15B), less than Agilent Technologies, Inc. (42.04B), greater than Medpace Holdings, Inc. (10.08B),

Build a custom stock screener for Charles River Laboratories International, Inc. (CRL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Charles River Laboratories International, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Charles River Laboratories International, Inc. (CRL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Charles River Laboratories International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Charles River Laboratories International, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Charles River Laboratories International, Inc. (CRL)?

What is the 3-year average Enterprise Value for Charles River Laboratories International, Inc. (CRL)?

What is the 5-year average Enterprise Value for Charles River Laboratories International, Inc. (CRL)?

How does the current Enterprise Value for Charles River Laboratories International, Inc. (CRL) compare to its historical average?